Fidelity Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs > Arena Pharmaceuticals, Inc. (ARNA)

Looking great today!!! Maybe there will be no

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Globaltrnr Member Profile
 
Followed By 68
Posts 7,304
Boards Moderated 0
Alias Born 10/12/09
160x600 placeholder
Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension "PR Newswire (US)" - 9/2/2014 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/27/2014 7:52:46 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/6/2014 4:34:28 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/1/2014 8:18:39 AM
Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results "PR Newswire (US)" - 8/1/2014 4:30:00 AM
Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obe... "PR Newswire (US)" - 7/30/2014 8:00:00 AM
Eisai and Arena Pharmaceuticals Announce BELVIQ® (lorcaserin HCl) CIV Nominated a Second Time for the Prix Galien Award in t... "PR Newswire (US)" - 7/29/2014 8:00:00 AM
Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 "PR Newswire (US)" - 7/25/2014 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/21/2014 4:33:20 PM
Arena Pharmaceuticals Enters into Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) in Israel "PR Newswire (US)" - 7/21/2014 8:00:00 AM
Arena Pharmaceuticals Issued Patent for APD371 by United States Patent and Trademark Office "PR Newswire (US)" - 7/15/2014 4:31:00 PM
Arena Pharmaceuticals Reports that Eisai Completes Planned Increase in Sales Force for BELVIQ® (lorcaserin HCl) CIV "PR Newswire (US)" - 7/10/2014 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2014 4:38:31 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/27/2014 6:50:01 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/13/2014 5:23:37 PM
Arena Pharmaceuticals to Present at the 2014 Wells Fargo Securities Healthcare Conference "PR Newswire (US)" - 6/13/2014 8:00:00 AM
Lorcaserin HCl Data to be Presented at American Diabetes Association's 74th Scientific Sessions "PR Newswire (US)" - 6/9/2014 7:55:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/3/2014 8:15:29 AM
Arena Pharmaceuticals Initiates Phase 1b Clinical Trial of APD334 for Autoimmune Diseases "PR Newswire (US)" - 6/3/2014 8:00:00 AM
Arena Pharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference "PR Newswire (US)" - 5/27/2014 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/14/2014 7:34:50 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/12/2014 4:16:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/12/2014 4:11:21 PM
Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2014 Financial Results "PR Newswire (US)" - 5/12/2014 4:03:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/9/2014 12:09:58 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist